1887

Abstract

An established mouse model was used to evaluate the effectiveness of the major outer core protein of African horsesickness virus (AHSV), VP7, as a subunit vaccine. Adult female BALB/c mice were immunized with VP7 crystals purified from BHK cells infected with AHSV serotype 9 (AHSV-9), using three inoculations in Freund’s adjuvant. Eighty to one hundred per cent of the immunized mice were protected against a heterologous challenge with a known lethal dose of AHSV-7. The protected immunized mice did not develop any clinical signs characteristic of virulent AHSV infection in this model during the study. In contrast, 80–100% mortality was observed in the non-immunized mice that received the same challenge virus. Subsequent studies indicated that a single inoculation of 1·5 µg purified AHSV VP7 in Freund’s complete adjuvant was sufficient to protect at least 90% of mice from AHSV-7 challenge. If the antigen was presented in the absence of Freund’s complete adjuvant, 70% of the mice were still protected by one inoculation of VP7 crystals. Titres of circulating antibody against AHSV VP7, determined by competitive ELISA, did not appear to correlate with protection and passive antibody transfer from immunized BALB/c mice failed to protect syngeneic recipients from AHSV-7 challenge. Therefore, the observed protection is unlikely to be due to an antibody-mediated immune response. The number of viraemic mice and the duration of viraemia post-challenge was significantly reduced in vaccinated mice compared to non- vaccinated controls. However, the levels of viraemia were similar.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-7-1611
1997-07-01
2024-06-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/7/9225037.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-7-1611&mimeType=html&fmt=ahah

References

  1. Anderson J., Mertens P. P. C., Herniman K. A. J. 1993; A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against bluetongue virus non-structural protein NS1. Journal of Virological Methods 43:167–176
    [Google Scholar]
  2. Angove H. L. 1995; The identification of bluetongue virus T-cell epitope(s) in sheep.A thesis submitted in partial fulfilment of the requirements of the University of Hertfordshire for the degree of PhD.
    [Google Scholar]
  3. Borden E. C., Shope R. E., Murphy F. A. 1971; Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus - a new taxonomic group. Physiochemical and serological studies. Journal of General Virology 13:261–271
    [Google Scholar]
  4. Burroughs J. N., O’Hara R. S., Smale C. J., Hamblin C., Walton A., Armstrong R., Mertens P. P. C. 1994; Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9. Journal of General Virology 75:1849–1857
    [Google Scholar]
  5. Cowley J. A., Gorman B. M. 1989; Cross-neutralisation of genetic reassortants of bluetongue virus serotypes 20 and 21. Veterinary Microbiology 19:37–51
    [Google Scholar]
  6. Erasmus B. J. 1963; Preliminary observations on the value of the guinea-pig in determining the innocuity and antigenicity of neurotropic attenuated horsesickness strains. Ondersterpoort Journal of Veterinary Research 30:11–22
    [Google Scholar]
  7. Erasmus B. J. 1978; A new approach to polyvalent immunisation against African horsesickness. In Equine Infectious Diseases 4 pp 401–403 Bryans J. T., Gerber H. Edited by New Jersey: Veterinary Publications;
    [Google Scholar]
  8. Gumm I. D., Newman J. F. E. 1982; The preparation of purified bluetongue virus group antigen for use as a diagnostic reagent. Archives of Virology 72:83–93
    [Google Scholar]
  9. Hamblin C., Graham S. D., Anderson E. C., Crowther J. R. 1990; A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiology and Infection 104:303–312
    [Google Scholar]
  10. Hamblin C., Mertens P. P. C., Mellor P. S., Burroughs J. N., Crowther J. R. 1991; A serogroup specific enzyme-linked immunosorbent assay for the detection of African horse sickness virus. Journal of Virological Methods 31:285–292
    [Google Scholar]
  11. Holmes I. H., Boccardo G., Estes M. K., Furuichi M. K., Hoshino Y., Joklik W. K., McCrae M., Mertens P. P. C., Milne R. G., Samal K. S. K., Shiata E., Winton J. R., Uyeda I., Nuss D. L. 1995; The Reoviridae. In Virus Taxonomy. Sixth Report ofthe International Committee on Taxonomy of Viruses pp 208–239 Murphy F. A., Fauquet C. M., Bishop D. H. L., Ghabrial S. A., Jarvis A. W., Martelli G. P., Mayo M. A., Summers M. D. Edited by Vienna & New York: Springer-Verlag;
    [Google Scholar]
  12. Howell P. G. 1962; The isolation and identification of further antigenic types of African horsesickness virus. Onderstepoort Journal of Veterinary Research 29:139–149
    [Google Scholar]
  13. Huismans H., Cloete M., Le Roux A. 1987; The genetic relatedness of a number of individual cognate genes of virus in the bluetongue and closely related serogroups. Virology 161:421–428
    [Google Scholar]
  14. Jeggo M. H., Wardley R. C., Brownlie J. 1984; A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 52:403–410
    [Google Scholar]
  15. Jeggo M. H., Wardley R. C., Brownlie J., Corteyn A. H. 1986; Serial inoculation of sheep with two bluetongue virus types. Research in Veterinary Science 40:386–392
    [Google Scholar]
  16. Karber G. 1931; Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Archiv fuer Experimentelle Pathologie und Pharmakologie 162:480–483
    [Google Scholar]
  17. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
    [Google Scholar]
  18. Laviada M. D., Roy P., Sanchez-Vizcaino J. M., Casal J. I. 1995; The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses. Virus Research 38:205–218
    [Google Scholar]
  19. Lubroth J. 1988; African horse sickness and the epizootic in Spain 1987. Equine Practice 10:26–33
    [Google Scholar]
  20. McIntosh B. M. 1958; Immunological types of horsesickness virus and their significance in immunisation. Ondersterpoort Journal of Veterinary Research 27:465–538
    [Google Scholar]
  21. Martínez-Torrecuadrada J. L., Díaz-Laviada M., Roy P., Sánchez C., Vela C., Sanchez-Vizcaíno J. M., Casal J. I. 1996; Full protection against African horsesickness (AHS) in horses induced by baculovirus- derived AHS virus serotype 4 VP2, VP5 and VP7. Journal of General Virology 77:1211–1221
    [Google Scholar]
  22. Mellor P. 1993; African horse sickness transmission and epidemiology. Veterinary Research 24:199–212
    [Google Scholar]
  23. Mertens P. P. C., Burroughs J. N., Walton A., Welby M. P., Fu H., O’Hara R. S., Brookes S. M., Mellor P. S. 1996; Enhanced infectivities of modified bluetongue virus for two insect cell lines and for two Culicoides vector species. Virology 217:582–593
    [Google Scholar]
  24. Nuttall P. A., Jacobs S. C., Jones L. D., Carey D., Moss S. R. 1992; Enhanced neurovirulence of tick-borne Orbiviruses resulting from genetic modulation. Virology 187:407–412
    [Google Scholar]
  25. O’Hara R. S. 1994; Identification of the genome segments and proteins controlling the virulence of African horsesickness virus. Thesis submitted in part for the degree of PhD University of Reading;
    [Google Scholar]
  26. Roy P. 1995; Towards the control of African horse sickness by recombinant technology. Equine Infectious Diseases 7:65–70
    [Google Scholar]
  27. Taylor M. B., van der Meyden C. H., Erasmus B. J., Reid R., Labuschagne J. H., Dreyer L., Prozesky O. W. 1992; Encephalitis and chorioretinitis associated with neurotropic African horse sickness virus infection in laboratory workers. IV. Experimental infection of the vervet monkey Cercopithecus pygerythrus. South African Medical Journal 81:462–467
    [Google Scholar]
  28. van der Meyden C. H., Erasmus B. J., Swanepoel R., Prozesky O. W. 1992; Encephalitis and chorioretinitis associated with neurotropic African horse sickness virus infection in laboratory workers. I. Clinical andneurological observations. SouthAfricanMedical Journal 81:451–454
    [Google Scholar]
  29. Wade-Evans A. M., Woolhouse T., O’Hara R., Hamblin C. 1993; The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA. Journal of Virological Methods 45:179–188
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-7-1611
Loading
/content/journal/jgv/10.1099/0022-1317-78-7-1611
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error